About Josh

Josh Stein is a highly-regarded serial entrepreneur and technology leader focused on using simple, smart design to improve healthcare. With an MBA from Wharton and a background that includes working with successful New York startups like Lot18 and FreshDirect, Josh combined his business expertise with his passion for solving real-world problems. He is the CEO and Co-Founder of AdhereTech, a company that developed a patented “smart pill bottle.” This device uses built-in cellular technology to track when a patient takes their medication in real-time. If a dose is missed, the system automatically sends personalized reminders to the patient via text or phone call. This technology is a vital tool in fighting medication non-adherence, a major problem in healthcare. AdhereTech’s data-driven approach is actively used by major pharmaceutical companies, health systems, and clinical researchers, and studies show it improves patient adherence by over 20% and time-on-therapy by over 30%. Josh’s vision successfully transformed AdhereTech from a simple device maker into a sophisticated adherence platform driven by data analytics and software. Recognized as a top innovator by organizations like the American Diabetes Association and Forbes, Josh is a frequent speaker at major health and technology events. He is known for his commitment to patient-centric design, emphasizing that technology must be “smart about the people using the technology.” In his younger days, he even dabbled in stand-up comedy.

SPECIAL SESSION: INNOVATION IN FOCUS
Shifting the Curve from Start to Scale to Exit: Lessons from the Trajectory of Innovation
Discussion Group

Giovanni Colella co-founded Castlight Health in 2008, along with Todd Park (currently U.S. chief technology officer and formerly the CTO of the U.S. Department of Health and Human Services) and Bryan Roberts of Venrock.

Prior to co-founding Castlight, Giovanni was Founder, President and CEO of RelayHealth, which was acquired by McKesson. Giovanni graduated with an M.D. from the Universita Degli Studi di Milano in Italy and earned his M.B.A. from Columbia Business School.

SPECIAL SESSION: INNOVATION IN FOCUS
Shifting the Curve from Start to Scale to Exit: Lessons from the Trajectory of Innovation
Moderator

Mr. Enriquez is an experienced business leader, author, and academic who is recognized as one of the world’s leading authorities on the economic and political impacts of life sciences. He is a Managing Director in Excel Venture Management, a venture capital firm that invests in companies that apply transformative life science technologies to solve problems in healthcare and beyond.

He was the founding director of Harvard Business School’s Life Sciences Project. He then founded Biotechonomy LLC, a life sciences research and investment firm, where he remains as Chairman and CEO. In July of 2005, he co-founded Synthetic Genomics, Inc., a synthetic biology company focused on developing and commercializing genomic-driven solutions to address global energy, medicine, clean water, and food challenges. He has been an active investor in early-stage private companies in the biotechnology and information sciences sectors. While at Harvard, he wrote various articles and case studies, won a McKinsey Prize, and published the best-selling As the Future Catches You, an analysis of the impact of genomics on business and society. His most recent publication is an eBook co-authored with Dr. Steve Gullans, Homo Evolutis: A Short Tour of our New Species, which describes a world where humans increasingly shape their environment, themselves, and other species. Mr. Enriquez serves on a number of boards including Cabot Corporation, Synthetic Genomics, Catch.com, Shape Up, the Public Interfaces Steering Committee of the Division of Earth & Life Sciences of the National Academy of Sciences, The Genetics Advisory Council of Harvard Medical School, The Chairman’s International Council of the America’s Society, and the Visiting Committee of Harvard’s David Rockefeller Center.

He earned a BA and MBA from Harvard, with Honors.

SPECIAL SESSION: INNOVATION IN FOCUS
Shifting the Curve from Start to Scale to Exit: Lessons from the Trajectory of Innovation
Discussion Group

Michael is Founder and CEO of Humedica, recently acquired by UnitedHealth Group. Previously, he was CEO of PharMetrics, which was sold to IMS Health in 2005. Michael has 30 years of experience in healthcare information technology. He is Founding Chairman of Phreesia, and sits on the Board of the medical informatics subsidiary of the American Medical Group Association (AMGA).  Michael is on the Board of JDRF New England Chapter. He received his MBA from Harvard Business School and his BA in Economics from Brandeis University.

SPECIAL SESSION: INNOVATION IN FOCUS
Shifting the Curve from Start to Scale to Exit: Lessons from the Trajectory of Innovation
Discussion Group

Nina Nashif is Founder and CEO of Healthbox, a business accelerator created to support early-stage entrepreneurs and stimulate innovation in the healthcare industry.

Nina is best known for her expertise in creating entrepreneurial ventures and leading high performing teams to achieve results. Her background includes more than ten years of global business experience within very different organizational settings. 

Nina has been recognized by the World Economic Forum as a Young Global Leader and by Crain’s Chicago Business as a 40 Under 40.